This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Dr. Michael Murphy, PhD
Director, Research at Celldex Therapeutics
Speaker

Agenda Sessions

  • The Discovery and Clinical Development of the anti-KIT Monoclonal Antibody Barzolvolimab

    , 12:00
    View Session

At this event

Prev
Next
Jane Osbourn, PhD
CEO
Alchemab Therapeutics

See Michael at Antibody Engineering & Therapeutics Europe

BOOK NOW